EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...
The City of Amarillo has extended the application deadline for the Business Improvement Grant (BIG) Program. The deadline to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback